PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA.\', \'Division of Cardiology, Department of Internal Medicine, Pauley Heart Center, Virginia Commonwealth University, Richmond, VA.\', \'Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy.\', \'Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.\', \'Division of Cardiology, Department of Medical Science, University of Turin, Turin, Italy.\', \'Department of Medicine, University Health Agency Giuliano Isontina, \'San Giovanni di Dio\' Hospital, Gorizia, Italy.\', \'Department of Cardiology, Niguarda Hospital, Milan, Italy.\', \'Department of Medico-Surgical Sciences and Biotechnologies Sapienza\', University of Rome, Rome, Italy.\', \'Mediterranea Cardiocentro, Napoli, Italy; and.\', \'Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/FJC.0000000000000836
?:hasPublicationType
?:journal
  • Journal of cardiovascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32282502
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.917
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all